Reported Aug 21, 2019 · Terminated
ADO-TRASTUZUMAB 210 MG/250 ml NS; ADO-TRASTUZUMAB E 213 MG / 250 ML NS; ADO-TRASTUZUMAB 242 MG/250 ml NS;…
Infusion Options, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Infusion Options, Inc. · 5924 13th Ave · Brooklyn, NY · 11219-4934
Is this the product you have?
7 of 7 products
| # | Product as published |
|---|---|
| 1 | ADO-TRASTUZUMAB 210 MG/250 ml NS |
| 2 | ADO-TRASTUZUMAB E 213 MG / 250 ML NS |
| 3 | ADO-TRASTUZUMAB 242 MG/250 ml NS |
| 4 | ADO-TRASTUZUMAB EMT 168 mg / 250 ml NS |
| 5 | ADO-TRASTUZUMAB E 160 MG / 250 ML NS ADO-TRASTUZUMAB 150 mg / 250 ml NS |
| 6 | ADO-TRASTUZUMAB EMT 301 mg / 250 ml NS |
| 7 | ADO-TRASTUZUMAB EMTANSINE 230mg/250ml NS IV Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233 |
- Lot codes and dates
- All lots within expiry
- Amount recalled
- N/A
This recall covers 76 products
The agency filed one notice per product. You are reading one of them; the other 75 are below.
63 more are in the archive.
Where it was sold
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Infusion Options, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.